(Q53060635)

English

Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.

scientific article published on 12 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

author name string

Ayumi Maeda

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Megumi Ishii

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Takeshi Ishii

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Mitsugu Akagawa

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

publication date

12 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

58

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

1177-1189

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Management of type 2 diabetes: new and future developments in treatment

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Regulation of glucose transport by insulin: traffic control of GLUT4.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Insulin signalling and the regulation of glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Protein tyrosine phosphatase: enzymatic assays

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cycling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Structural characteristics of green tea catechins for formation of protein carbonyl in human serum albumin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Characterization of volatile components of Iranian saffron using factorial-based response surface modeling of ultrasonic extraction combined with gas chromatography-mass spectrometry analysis.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Qualitative determination of volatile compounds and quantitative evaluation of safranal and 4-hydroxy-2,6,6-trimethyl-1-cyclohexene-1-carboxaldehyde (HTCC) in Greek saffron

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Inhibitors of protein tyrosine phosphatases: next-generation drugs?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

PTP1B: a double agent in metabolism and oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Neuronal PTP1B regulates body weight, adiposity and leptin action.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Insights into the Reaction of Protein-tyrosine Phosphatase 1B: CRYSTAL STRUCTURES FOR TRANSITION STATE ANALOGS OF BOTH CATALYTIC STEPS

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300675

21 January 2018

Identifiers

10.1002/MNFR.201300675

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24668740

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53060635&oldid=1318713807"